Hans‐Joachim Wittmann

Synthesis, Biological Evaluation, and Computational Studies of Tri- and Tetracyclic Nitrogen-Bridgehead Compounds as Potent Dual-Acting AChE Inhibitors and<i>h</i>H₃Receptor Antagonists

Fouad H. Darras, Steffen Pockes, Guozheng Huang et al. · ACS Chemical Neuroscience · 2014 · 77 citations · Full text

New insights into the cross-linking and degradation mechanism of Diels–Alder hydrogels

Susanne Kirchhof, Hans‐Joachim Wittmann, Viktoria Messmann et al. · Journal of Materials Chemistry B · 2014 · 74 citations · Full text

Structure–Activity Relationships and Computational Investigations into the Development of Potent and Balanced Dual-Acting Butyrylcholinesterase Inhibitors and Human Cannabinoid Receptor 2 Ligands with Pro-Cognitive in Vivo Profiles

Dominik Dolles, Matthias Hoffmann, Sandra Gunesch et al. · Journal of Medicinal Chemistry · 2018 · 62 citations · Full text

Pharmacological Profile of Histaprodifens at Four Recombinant Histamine H1 Receptor Species Isoforms

Andrea Straßer, Birgit Striegl, Hans‐Joachim Wittmann et al. · Journal of Pharmacology and Experimental Therapeutics · 2007 · 45 citations

Aminobenzimidazoles and Structural Isomers as Templates for Dual‐Acting Butyrylcholinesterase Inhibitors and <i>h</i>CB₂R Ligands To Combat Neurodegenerative Disorders

Dominik Dolles, Martin Nimczick, Matthias Scheiner et al. · ChemMedChem · 2015 · 36 citations

Drug Target, Chemical Biology, Molecular Dynamics +19